Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in corticoadrenal carcinoma (malignant progression) |
constitutional
| somatic mutation
|  
|  
|  
|
mutations creating null alleles cause tau-negative frontotemporal dementia |
tumoral
|  
|  
| --over
|  
|
in uterine leiomyosarcoma |
constitutional
|  
| deletion
|  
|  
|
sufficient to cause neurodegeneration |
constitutional
|  
| deletion
|  
|  
|
deleted with RUNDC3A in frontotemporal dementia |
constitutional
|  
|  
|  
| loss of function
|
leads to dysregulated microglial activation and thereby contributes to increased neuron loss with injury  |
tumoral
|  
|  
| --over
|  
|
in hepatocellular carcinoma but not in the adjacent non-tumor  |
constitutional
|  
|  
| --low
|  
|
in 65 p100 of children with autism  |
constitutional
|  
|  
| --over
|  
|
increased GRN in the skin of amyotrophic lateral sclerosis, related to the disease process and metabolic alteration of GRN may take place in the skin of patients with ALS  |
constitutional
|  
|  
| --over
|  
|
in Alzheimer disease brains, whereas TMEM106B mRNA levels were decreased  |
constitutional
|  
|  
| --low
| gain of function
|
both PSAP reduction and overexpression lead to significantly elevated extracellular GRN levels  |